WebJan 13, 2024 · Arch Oncology ended its work on developing an anti-CD47 antibody and most employees have left the company, Endpoints News has learned. The Brisbane, CA, … WebNov 5, 2024 · William Casey Wilson, John O Richards, Gabriela Andrejeva, Benjamin J Capoccia, Robyn J Puro, Mike J Donio, Ronald R Hiebsch, Arun K Kashyap, Daniel S Pereira; AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms.
Jackie Walling Email & Phone Number - Arch Onco.. ZoomInfo
WebJan 13, 2024 · Arch Oncology ended its work on developing an anti-CD47 antibody and most employees have left the company, Endpoints News has learned. WebMar 19, 2024 · Vice President, Finance at Arch Oncology . Kirsten Anderson is a Vice President, Finance at Arch Oncology based in Brisbane, California. Previously, Kirsten was a Director at Danforth Advis ors and also held positions at Anderson & Associates, Ewald Consulting, Dehn's Country Manor, AspireMN, Mintahoe Catering & Events, St. Olaf … energean companies house
28 Startups Biotech
WebWe have built a stellar team of over 130 people across three sites (San Diego, Stamford and Watertown) and at large. Our internal R&D team is equally weighted across biology, chemistry, protein sciences and computation. We are privileged to have an extremely capable internal IP team and G&A colleagues who are fully integrated into our drug ... WebArch manages private investment operations for leading investors and investment advisors, reinventing private portfolio management through a digital solution that replaces … WebArch Oncology 2,339 followers on LinkedIn. Arch Oncology, Inc. is a clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies for the treatment of patients with solid tumors and hematologic malignancies. Our lead product candidate AO-176 is in Phase 1/2 clinical trials for the … energas south africa